An agreement with Endo International PLC to resolve thousands of lawsuits over transvaginal mesh devices is unlikely to sway other manufacturers to immediately settle, according to lawyers involved in the litigation.
The deal, estimated to be worth about $830 million, resolves 20,000 claims against Endo’s Minneapolis subsidiary, American Medical Systems Inc., the company said on April 30. The deal is the largest to come out of the mesh litigation—but that doesn’t mean other manufacturers are scrambling to craft their own agreements. In fact, two of the largest defendants—Johnson & Johnson and Boston Scientific Corp.—are preparing for trials this year.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
